Statins may speed up onset of Parkinson's symptoms

Image
IANS New York
Last Updated : Jun 15 2017 | 12:02 PM IST

Statins, generally used to treat high cholesterol, may speed up the onset of Parkinson's disease symptoms in people who are susceptible to the disease, says a study.

The findings challenge prevalent perceptions. A recent study reported that people who stopped using statins were more likely to be diagnosed with Parkinson's disease, a finding interpreted as evidence that statins protect against Parkinson's disease.

"Our new data suggests a different explanation," said Xuemei Huang, Professor at Penn State College of Medicine in the US.

"Use of statins may lead to new Parkinson's disease-related symptoms, thus causing patients to stop using statins," Huang explained.

Another reason for the inconsistent results is that there are two types of statins.

Water-soluble statins cannot get into the brain, while fat-soluble statins, called lipophilic, can.

Since people with high cholesterol are treated for both kinds, the interpretation of results as it relates to Parkinson's disease is not easy.

The researchers analysed data in a commercially-available database of insurance claims for more than 50 million people.

They identified nearly 22,000 people with Parkinson's disease, and narrowed the number to 2,322 patients with newly diagnosed Parkinson's disease.

They paired each Parkinson's patient with a person in the database who did not have Parkinson's -- called a control group.

Researchers then determined which patients had been taking a statin and for how long before Parkinson's disease symptoms appeared.

The study, published in the journal Movement Disorders, showed that prior statin use was associated with higher risk of Parkinson's disease and was more noticeable during the start of the drug use.

"Statin use was associated with higher, not lower, Parkinson's disease risk, and the association was more noticeable for lipophilic statins, an observation inconsistent with the current hypothesis that these statins protect nerve cells," Huang said.

--IANS

gb/pgh/

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 15 2017 | 11:54 AM IST

Next Story